Developments in renal pharmacogenomics and applications in chronic kidney disease
about
Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal DiseasesTenofovir is associated with increased tubular proteinuria and asymptomatic renal tubular dysfunction in Ghana.Shen-Kang protects 5/6 nephrectomized rats against renal injury by reducing oxidative stress through the MAPK signaling pathways.Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children
P2860
Developments in renal pharmacogenomics and applications in chronic kidney disease
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Developments in renal pharmacogenomics and applications in chronic kidney disease
@ast
Developments in renal pharmacogenomics and applications in chronic kidney disease
@en
Developments in renal pharmacogenomics and applications in chronic kidney disease
@nl
type
label
Developments in renal pharmacogenomics and applications in chronic kidney disease
@ast
Developments in renal pharmacogenomics and applications in chronic kidney disease
@en
Developments in renal pharmacogenomics and applications in chronic kidney disease
@nl
prefLabel
Developments in renal pharmacogenomics and applications in chronic kidney disease
@ast
Developments in renal pharmacogenomics and applications in chronic kidney disease
@en
Developments in renal pharmacogenomics and applications in chronic kidney disease
@nl
P2860
P356
P1476
Developments in renal pharmacogenomics and applications in chronic kidney disease
@en
P2093
Inés Llaudó
Núria Lloberas
P2860
P304
P356
10.2147/PGPM.S52763
P407
P577
2014-08-28T00:00:00Z